Literature DB >> 9129785

Neuropsychological and cognitive psychophysiological substrates of impulsive aggression.

E S Barratt1, M S Stanford, T A Kent, A Felthous.   

Abstract

The purpose of this study was to test whether subjects who commit impulsive vs non-impulsive aggression differ on measurements of personality, neuropsychology, and cognitive psychophysiology, and whether these differences can yield information regarding the etiology of impulsive aggression. Subjects were two groups of prison inmates, distinguished by their committal of impulsive or nonimpulsive aggression, and matched noninmate controls. All inmates met DSM III-R criteria for an antisocial personality disorder but for no other disorder. Impulsiveness, anger, and peak P300 latencies did not differ between the inmate groups, but verbal symbol decoding and peak P300 amplitudes did. Impulsiveness and verbal skills were inversely correlated. Impulsiveness was inversely correlated with, and verbal skills positively correlated with P300 amplitudes. The results indicate that aggression is not homogenous, even among antisocial persons, and that impulsive aggression is related to neuropsychological and cognitive psychophysiological measures of information processing beyond those factors related to criminality alone.

Entities:  

Mesh:

Year:  1997        PMID: 9129785     DOI: 10.1016/s0006-3223(96)00175-8

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  47 in total

Review 1.  Gene-environment interplay in alcoholism and other substance abuse disorders: expressions of heritability and factors influencing vulnerability.

Authors:  Tomas Palomo; R M Kostrzewa; R J Beninger; T Archer
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

2.  Violent offending predicts P300 amplitude.

Authors:  Edward M Bernat; Jason R Hall; Benjamin V Steffen; Christopher J Patrick
Journal:  Int J Psychophysiol       Date:  2007-05-03       Impact factor: 2.997

Review 3.  Psychophysiological correlates of aggression and violence: an integrative review.

Authors:  Christopher J Patrick
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2008-08-12       Impact factor: 6.237

4.  Reduction of frontal neocortical grey matter associated with affective aggression in patients with temporal lobe epilepsy: an objective voxel by voxel analysis of automatically segmented MRI.

Authors:  F G Woermann; L T van Elst; M J Koepp; S L Free; P J Thompson; M R Trimble; J S Duncan
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-02       Impact factor: 10.154

Review 5.  Pharmacological interventions for antisocial personality disorder.

Authors:  Najat Khalifa; Conor Duggan; Jutta Stoffers; Nick Huband; Birgit A Völlm; Michael Ferriter; Klaus Lieb
Journal:  Cochrane Database Syst Rev       Date:  2010-08-04

6.  Pilot pharmacologic randomized controlled trial for psychogenic nonepileptic seizures.

Authors:  W C LaFrance; G I Keitner; G D Papandonatos; A S Blum; J T Machan; C E Ryan; I W Miller
Journal:  Neurology       Date:  2010-08-25       Impact factor: 9.910

7.  Substance use disorders: Relationship with intermittent explosive disorder and with aggression, anger, and impulsivity.

Authors:  Emil F Coccaro; Daniel J Fridberg; Jennifer R Fanning; Jon E Grant; Andrea C King; Royce Lee
Journal:  J Psychiatr Res       Date:  2016-06-16       Impact factor: 4.791

8.  Is impulsivity a common trait in bipolar and unipolar disorders?

Authors:  Elaine Henna; John P Hatch; Mark Nicoletti; Alan C Swann; Giovana Zunta-Soares; Jair C Soares
Journal:  Bipolar Disord       Date:  2013-01-03       Impact factor: 6.744

Review 9.  Intermittent explosive disorder: epidemiology, diagnosis and management.

Authors:  Rene L Olvera
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

10.  BIS-11A -Hindi version: A preliminary study of impulsivity in rural and urban Indian adolescents.

Authors:  Paramjeet Singh; R K Solanki; P S Bhatnagar
Journal:  Indian J Psychiatry       Date:  2008-04       Impact factor: 1.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.